Boryung (003850) Fundamentals 2026 — P/E 6.4x, Revenue Analysis | SniperIQ
Boryung (003850) is a KR-listed Healthcare company in Medical - Pharmaceuticals with a market capitalization of ₩673.3B, trading at ₩7970.00 on the KSC. This SniperIQ fundamentals page covers Boryung's valuation (P/E 6.4x, P/B 0.8x), profitability (net margin 10.2%), revenue (₩1.02T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Boryung's market cap?
Boryung (003850) has a market capitalization of approximately ₩673.3B, trading at ₩7970.00 on the KSC. Market cap moves with the live share price.
What is Boryung's P/E ratio?
Boryung's trailing twelve-month P/E ratio is 6.4x, with a price-to-book (P/B) of 0.8x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Boryung?
Boryung runs a net profit margin of 10.2%, a gross margin of 35.4%, and an operating margin of 7.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Boryung generate?
Boryung reported revenue of ₩1.02T for fiscal year 2025, with net income of ₩64.3B and earnings per share (EPS) of 765.85. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Boryung pay a dividend?
Boryung offers a trailing dividend yield of about 2.0%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Boryung financially healthy?
Boryung carries a debt-to-equity ratio of 0.33x and a current ratio of 2.61x, with a market beta of 0.33. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Boryung a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Boryung (003850) the key facts are: market cap ₩673.3B, P/E 6.4x, revenue ₩1.02T, 52-week range 7910-10800. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Boryung's full fundamentals live
Get Boryung's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.